ReviewOpen Access
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists
Author Affiliations
Mediprobe Research (Canada), BRAC University, Baylor College of Medicine, University of Toronto, ...
Published InAmerican Journal of Clinical Dermatology
Year2023
Citations65
Abstract
The current 2022 mpox (monkeypox) outbreak has been officially recognized as a public health emergency. The mpox clinical symptoms include high fever, fatigue, chills, headache, swollen lymph nodes, muscle aches, and a disseminated painful rash. However, recent cases of mpox have shown a shift in clinical symptoms, with anogenital skin lesions emerging as the predominant feature. Due to the predominant skin manifestations of mpox, dermatologists could be crucial in detecting new mpox cases and educating frontline healthcare professionals about mpox. The mpox virus is continuously evolving and has several variants. Genome sequencing has revealed that the Clade IIb variant is responsible for the 2022 mpox outbreak. Mpox spread may occur through animal-to-human and human-to-human transmission; however, unlike coronavirus disease 2019…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.